Smith & Nephew PLC, a leading global medical technology company, has announced the timing for its third quarter 2026 trading report. The report is scheduled to be released on November 4, 2026, at 7:00 AM GMT / 2:00 AM EST. This announcement is crucial as it will provide insights into the company's financial performance and strategic direction within the competitive orthopedic and surgical supplies industry.
Founded in 1856 and headquartered in Watford, Hertfordshire, Smith & Nephew operates in over 100 countries and generated annual sales of $6.2 billion in 2025. The company specializes in the repair, regeneration, and replacement of soft and hard tissue, focusing on enhancing patient outcomes through innovative medical technologies. Smith & Nephew is listed on both the NYSE and the London Stock Exchange under the ticker symbols SNN and SN, respectively.
The filing, dated October 8, 2026, reveals that the trading report will be followed by a conference call for financial analysts at 12:00 PM GMT / 7:00 AM EST. Details regarding the call will be available on the company's investor relations website. This proactive approach to investor communication reflects Smith & Nephew's commitment to transparency and accountability.
The upcoming trading report is expected to impact various stakeholders, including investors, analysts, and competitors in the orthopedic, prosthetic, and surgical appliances and supplies sector. As Smith & Nephew prepares to disclose its financial results, other companies in the industry will be keenly observing the data to gauge market trends and consumer behavior.
Looking ahead, the next significant event will be the release of the trading report on November 4, 2026. Investors and market analysts will be eager to assess the company's performance and strategic initiatives as they navigate the evolving landscape of the medical technology sector.